Ziopharm Oncology is focused on advancing the next generation of immunotherapies to weaponize the existing immune system with Controlled IL-12 or introduce new immune system elements with Sleeping Beauty-modified T cells to this fight against cancer. In addition to developing the next generation of immuno-oncology medicines that target multiple types of cancers, we also are targeting the cost and complexity of delivering gene and cell therapies.
Events & Presentations
Sep 9, 2019 4:15 PM EDT
Morgan Stanley 17th Annual Global Healthcare Conference
Aug 8, 2019 8:30 AM EDT
Ziopharm Second Quarter 2019 Earnings Call
Jun 12, 2019 8:30 AM EDT
Ziopharm Oncology Informational Conference Call